Apollomics, Inc. (APLM)
NASDAQ: APLM · Real-Time Price · USD
20.13
+0.07 (0.35%)
Mar 9, 2026, 2:05 PM EDT - Market open
Apollomics Market Cap
Apollomics has a market cap or net worth of $43.20 million as of March 9, 2026. Its market cap has increased by 311.55% in one year.
Market Cap
43.20M
Enterprise Value
41.70M
1-Year Change
311.55%
Ranking
Category
Stock Price
$20.13
Market Cap Chart
Since November 26, 2021, Apollomics's market cap has decreased from $129.59M to $43.20M, a decrease of -66.66%. That is a compound annual growth rate of -22.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 43.05M | 7.30% |
| Dec 31, 2025 | 40.12M | 273.20% |
| Dec 31, 2024 | 10.75M | -87.56% |
| Dec 29, 2023 | 86.40M | -37.89% |
| Dec 30, 2022 | 139.11M | 7.02% |
| Dec 30, 2021 | 129.98M | 0.30% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lipocine | 45.14M |
| Estrella Immunopharma | 44.98M |
| NextCure | 43.43M |
| Telomir Pharmaceuticals | 42.98M |
| Aligos Therapeutics | 42.95M |
| Lite Strategy | 41.45M |
| OnKure Therapeutics | 41.32M |
| Palatin Technologies | 40.78M |